Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature

Olugbenga Akindele Silas, Chad J. Achenbach, Robert Leo Murphy, Lifang Hou, Solomon Atiene Sagay, Edmund Banwat, Adeyi A. Adoga, Jonah Musa, Dustin Douglas French

Research output: Contribution to journalReview article

Abstract

Introduction: Low and middle income countries (LMICs) bear more than 50% of the current cervical cancer burden over the last decade with linkages to lack of HPV vaccination, high levels of poverty, illiteracy and nonexistent or poor screening programs. Governments of LMICs need enough convincing evidence that HPV vaccination will be more cost-effective in reducing the scourge of cervical cancer. Area covered: A systematic review to identify suitable studies from MEDLINE(via PubMed), EMBASE and Electronic search through GOOGLE for original and review articles from 2007 to 2014 on cost-effectiveness of human papilloma virus vaccination of pre-adolescent girls in LMICs was conducted. A total of 19 full articles were finally selected and reviewed after screening out those not consistent with the inclusion and exclusion criteria. Expert commentary: Most studies on cost-effectiveness of HPV vaccine in LMICs show that lowering cost of HPV vaccination with or without Pap smear screening is cost-effective in areas with high incidence of cervical cancer.

Original languageEnglish (US)
Pages (from-to)91-98
Number of pages8
JournalExpert Review of Vaccines
Volume17
Issue number1
DOIs
StatePublished - Jan 2 2018

Fingerprint

Papillomaviridae
Cost-Benefit Analysis
Vaccination
Uterine Cervical Neoplasms
Costs and Cost Analysis
Papanicolaou Test
Papillomavirus Vaccines
Poverty
PubMed
MEDLINE
Incidence

Keywords

  • Disability adjusted life
  • cervical cancer
  • gross domestic product
  • human papilloma virus
  • low and middle income countries

ASJC Scopus subject areas

  • Immunology
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

@article{02a67f7f03db49bbb2b911d9d9936d8d,
title = "Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature",
abstract = "Introduction: Low and middle income countries (LMICs) bear more than 50{\%} of the current cervical cancer burden over the last decade with linkages to lack of HPV vaccination, high levels of poverty, illiteracy and nonexistent or poor screening programs. Governments of LMICs need enough convincing evidence that HPV vaccination will be more cost-effective in reducing the scourge of cervical cancer. Area covered: A systematic review to identify suitable studies from MEDLINE(via PubMed), EMBASE and Electronic search through GOOGLE for original and review articles from 2007 to 2014 on cost-effectiveness of human papilloma virus vaccination of pre-adolescent girls in LMICs was conducted. A total of 19 full articles were finally selected and reviewed after screening out those not consistent with the inclusion and exclusion criteria. Expert commentary: Most studies on cost-effectiveness of HPV vaccine in LMICs show that lowering cost of HPV vaccination with or without Pap smear screening is cost-effective in areas with high incidence of cervical cancer.",
keywords = "Disability adjusted life, cervical cancer, gross domestic product, human papilloma virus, low and middle income countries",
author = "Silas, {Olugbenga Akindele} and Achenbach, {Chad J.} and Murphy, {Robert Leo} and Lifang Hou and Sagay, {Solomon Atiene} and Edmund Banwat and Adoga, {Adeyi A.} and Jonah Musa and French, {Dustin Douglas}",
year = "2018",
month = "1",
day = "2",
doi = "10.1080/14760584.2018.1411195",
language = "English (US)",
volume = "17",
pages = "91--98",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd.",
number = "1",

}

Cost effectiveness of human papilloma virus vaccination in low and middle income countries : a systematic review of literature. / Silas, Olugbenga Akindele; Achenbach, Chad J.; Murphy, Robert Leo; Hou, Lifang; Sagay, Solomon Atiene; Banwat, Edmund; Adoga, Adeyi A.; Musa, Jonah; French, Dustin Douglas.

In: Expert Review of Vaccines, Vol. 17, No. 1, 02.01.2018, p. 91-98.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Cost effectiveness of human papilloma virus vaccination in low and middle income countries

T2 - Expert Review of Vaccines

AU - Silas, Olugbenga Akindele

AU - Achenbach, Chad J.

AU - Murphy, Robert Leo

AU - Hou, Lifang

AU - Sagay, Solomon Atiene

AU - Banwat, Edmund

AU - Adoga, Adeyi A.

AU - Musa, Jonah

AU - French, Dustin Douglas

PY - 2018/1/2

Y1 - 2018/1/2

N2 - Introduction: Low and middle income countries (LMICs) bear more than 50% of the current cervical cancer burden over the last decade with linkages to lack of HPV vaccination, high levels of poverty, illiteracy and nonexistent or poor screening programs. Governments of LMICs need enough convincing evidence that HPV vaccination will be more cost-effective in reducing the scourge of cervical cancer. Area covered: A systematic review to identify suitable studies from MEDLINE(via PubMed), EMBASE and Electronic search through GOOGLE for original and review articles from 2007 to 2014 on cost-effectiveness of human papilloma virus vaccination of pre-adolescent girls in LMICs was conducted. A total of 19 full articles were finally selected and reviewed after screening out those not consistent with the inclusion and exclusion criteria. Expert commentary: Most studies on cost-effectiveness of HPV vaccine in LMICs show that lowering cost of HPV vaccination with or without Pap smear screening is cost-effective in areas with high incidence of cervical cancer.

AB - Introduction: Low and middle income countries (LMICs) bear more than 50% of the current cervical cancer burden over the last decade with linkages to lack of HPV vaccination, high levels of poverty, illiteracy and nonexistent or poor screening programs. Governments of LMICs need enough convincing evidence that HPV vaccination will be more cost-effective in reducing the scourge of cervical cancer. Area covered: A systematic review to identify suitable studies from MEDLINE(via PubMed), EMBASE and Electronic search through GOOGLE for original and review articles from 2007 to 2014 on cost-effectiveness of human papilloma virus vaccination of pre-adolescent girls in LMICs was conducted. A total of 19 full articles were finally selected and reviewed after screening out those not consistent with the inclusion and exclusion criteria. Expert commentary: Most studies on cost-effectiveness of HPV vaccine in LMICs show that lowering cost of HPV vaccination with or without Pap smear screening is cost-effective in areas with high incidence of cervical cancer.

KW - Disability adjusted life

KW - cervical cancer

KW - gross domestic product

KW - human papilloma virus

KW - low and middle income countries

UR - http://www.scopus.com/inward/record.url?scp=85039750100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039750100&partnerID=8YFLogxK

U2 - 10.1080/14760584.2018.1411195

DO - 10.1080/14760584.2018.1411195

M3 - Review article

VL - 17

SP - 91

EP - 98

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 1

ER -